Biologics News

A review of nearly 900 medical practice websites showed the clinical efficacy of stem cell therapy in direct-to-consumer advertising was not accurately represented in most practices.

The FDA and the Federal Trade Commission on Monday announced a partnership aimed at supporting the adoption of biosimilars and interchangeable products by deterring what they called “anti-competitive business practices,” such as false or misleading promotions, according to a joint statement.

KOLOA, Hawaii — At Orthopedics Today Hawaii, Jack M. Bert, MD, spoke about the concept of injectables for arthritis. Injectables, such as cortisone injections, have become important; however, he noted, these can cause damage to the joint surface. There are other injectables that will postpone the need for total knee replacement and include platelet-rich plasma and high-molecular-weight viscosupplements.

KOLOA, Hawaii — As interest in orthobiologics continues to grow, Matthew T. Provencher, MD, noted in a Facebook Live event hosted at Orthopedics Today Hawaii that orthopedists need to be cognizant of the exact definition of orthobiologics and where it fits within the specialty.

KOLOA, Hawaii — During a Facebook Live at Orthopedics Today Hawaii, Anthony A. Romeo, MD, and Matthew T. Provencher, MD, spoke about the use of orthobiologics in orthopedics.

KOLOA, Hawaii — Although it may be tempting to consider stem cell treatment in patients with painful knee osteoarthritis after a key proof-of-concept study showed mesenchymal stem cell injections improved knee OA symptoms, a presenter at Orthopedics Today Hawaii cautioned orthopedic surgeons to not jump on the stem cell bandwagon and claim such results can be achieved in all patients.

Results presented at the Limb Lengthening and Reconstruction Society Annual Scientific Meeting showed enhanced biologic activity in human induced membranes for bone defects persists for longer than previously suggested from results in animal models.

The Arthroscopy Association of North America, the American Orthopaedic Society for Sports Medicine, the International Cartilage Repair Society and the Orthoregeneration Network Foundation have collaborated to form the Biologics Alliance, which will discuss all issues on musculoskeletal biologics and regenerative medicine.

Repeat, routine testing for latent tuberculosis infection among patients receiving biologics is both costly and of low clinical value, according to findings presented at the 2019 ACR/ARP Annual Meeting.

Amniotic suspension allograft may be an effective nonoperative treatment of symptomatic knee osteoarthritis, according to recently published results.